{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T03:49:16Z","timestamp":1763696956756,"version":"3.45.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,20]]},"DOI":"10.7759\/cureus.97377","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T02:46:03Z","timestamp":1763693163000},"source":"Crossref","is-referenced-by-count":0,"title":["Psoriatic Arthritis Features and Risk of Cardiovascular Events: A Nationwide Cohort Study"],"prefix":"10.7759","author":[{"given":"Roel","family":"Sanchez Baez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur","family":"Kavanaugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Guma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel M","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090822","article-title":"Cardiovascular disease and risk factors in patients with psoriasis and psoriatic arthritis","volume":"37","author":"Tobin AM","year":"2010","unstructured":"Tobin AM, Veale DJ, Fitzgerald O, Rogers S, Collins P, O'Shea D, Kirby B. Cardiovascular disease and risk factors in patients with psoriasis and psoriatic arthritis. J Rheumatol. 2010, 37:1386-94. 10.3899\/jrheum.090822","journal-title":"J Rheumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780401021","article-title":"Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death","volume":"40","author":"Wong K","year":"1997","unstructured":"Wong K, Gladman DD, Husted J, Long JA, Farewell VT. Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death. Arthritis Rheum. 1997, 40:1868-72. 10.1002\/art.1780401021","journal-title":"Arthritis Rheum"},{"key":"ref3","article-title":"Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis","volume":"33","author":"Han C","year":"2006","unstructured":"Han C, Robinson DW Jr., Hackett MV, Paramore LC, Fraeman KH, Bala MV. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol. 2006, 33:2167-72.","journal-title":"J Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2006.09.001","article-title":"Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis","volume":"36","author":"Kimhi O","year":"2007","unstructured":"Kimhi O, Caspi D, Bornstein NM, et al.. Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis. Semin Arthritis Rheum. 2007, 36:203-9. 10.1016\/j.semarthrit.2006.09.001","journal-title":"Semin Arthritis Rheum"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.094839","article-title":"Cardiovascular morbidity in psoriatic arthritis","volume":"68","author":"Gladman DD","year":"2009","unstructured":"Gladman DD, Ang M, Su L, Tom BD, Schentag CT, Farewell VT. Cardiovascular morbidity in psoriatic arthritis. Ann Rheum Dis. 2009, 68:1131-5. 10.1136\/ard.2008.094839","journal-title":"Ann Rheum Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20627","article-title":"Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis","volume":"63","author":"Husted JA","year":"2011","unstructured":"Husted JA, Thavaneswaran A, Chandran V, Eder L, Rosen CF, Cook RJ, Gladman DD. Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis. Arthritis Care Res (Hoboken). 2011, 63:1729-35. 10.1002\/acr.20627","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson PW","year":"1998","unstructured":"Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998, 97:1837-47. 10.1161\/01.cir.97.18.1837","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.12267","article-title":"Framingham Risk Score underestimates cardiovascular disease risk in severe psoriatic patients: implications in cardiovascular risk factors management and primary prevention of cardiovascular disease","volume":"40","author":"Torres T","year":"2013","unstructured":"Torres T, Sales R, Vasconcelos C, Martins da Silva B, Selores M. Framingham Risk Score underestimates cardiovascular disease risk in severe psoriatic patients: implications in cardiovascular risk factors management and primary prevention of cardiovascular disease. J Dermatol. 2013, 40:923-6. 10.1111\/1346-8138.12267","journal-title":"J Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203433","article-title":"The Framingham Risk Score underestimates the extent of subclinical atherosclerosis in patients with psoriatic disease","volume":"73","author":"Eder L","year":"2014","unstructured":"Eder L, Chandran V, Gladman DD. The Framingham Risk Score underestimates the extent of subclinical atherosclerosis in patients with psoriatic disease. Ann Rheum Dis. 2014, 73:1990-6. 10.1136\/annrheumdis-2013-203433","journal-title":"Ann Rheum Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2024.152468","article-title":"Personalizing cardiovascular risk prediction for patients with systemic lupus erythematosus","volume":"67","author":"Choi MY","year":"2024","unstructured":"Choi MY, Guan H, Yoshida K, et al.. Personalizing cardiovascular risk prediction for patients with systemic lupus erythematosus. Semin Arthritis Rheum. 2024, 67:152468. 10.1016\/j.semarthrit.2024.152468","journal-title":"Semin Arthritis Rheum"},{"key":"ref11","unstructured":"Framingham Risk Score (function) policy. (2025). Accessed. October 17, 2025: https:\/\/www.framinghamheartstudy.org\/fhs-for-researchers\/policies-and-procedures\/framingham-risk-score-policy\/#:~:tex...."},{"key":"ref12","article-title":"Prevalence and characteristics associated with dactylitis in patients with early spondyloarthritis: results from the ESPeranza cohort","volume":"36","author":"T\u00e9var-S\u00e1nchez MI","year":"2018","unstructured":"T\u00e9var-S\u00e1nchez MI, Navarro-Comp\u00e1n V, Aznar JJ, Linares LF, Castro MC, De Miguel E. Prevalence and characteristics associated with dactylitis in patients with early spondyloarthritis: results from the ESPeranza cohort. Clin Exp Rheumatol. 2018, 36:879-883.","journal-title":"Clin Exp Rheumatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220964","article-title":"Dactylitis is an indicator of a more severe phenotype independently associated with greater SJC, CRP, ultrasound synovitis and erosive damage in DMARD-naive early psoriatic arthritis","volume":"81","author":"Dubash S","year":"2022","unstructured":"Dubash S, Alabas OA, Michelena X, et al.. Dactylitis is an indicator of a more severe phenotype independently associated with greater SJC, CRP, ultrasound synovitis and erosive damage in DMARD-naive early psoriatic arthritis. Ann Rheum Dis. 2022, 81:490-5. 10.1136\/annrheumdis-2021-220964","journal-title":"Ann Rheum Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-020-00242-3","article-title":"Impact of enthesitis on psoriatic arthritis patient-reported outcomes and physician satisfaction with treatment: data from a multinational patient and physician survey","volume":"7","author":"Orbai AM","year":"2020","unstructured":"Orbai AM, Birt JA, Holdsworth EA, Booth N, Malatestinic WN, Sprabery AT, Reginato AM. Impact of enthesitis on psoriatic arthritis patient-reported outcomes and physician satisfaction with treatment: data from a multinational patient and physician survey. Rheumatol Ther. 2020, 7:937-48. 10.1007\/s40744-020-00242-3","journal-title":"Rheumatol Ther"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207980","article-title":"Incidence and predictors for cardiovascular events in patients with psoriatic arthritis","volume":"75","author":"Eder L","year":"2016","unstructured":"Eder L, Wu Y, Chandran V, Cook R, Gladman DD. Incidence and predictors for cardiovascular events in patients with psoriatic arthritis. Ann Rheum Dis. 2016, 75:1680-6. 10.1136\/annrheumdis-2015-207980","journal-title":"Ann Rheum Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05088-2","article-title":"Enthesitis and joint erosions are disease traits associated with cardiovascular risk in psoriatic arthritis","volume":"39","author":"Lorenzo A","year":"2020","unstructured":"Lorenzo A, Pardo E, Charca L, Pino M, Queiro R. Enthesitis and joint erosions are disease traits associated with cardiovascular risk in psoriatic arthritis. Clin Rheumatol. 2020, 39:2973-9. 10.1007\/s10067-020-05088-2","journal-title":"Clin Rheumatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220782","article-title":"Nail involvement in psoriatic arthritis patients is an independent risk factor for carotid plaque","volume":"80","author":"Colunga-Pedraza IJ","year":"2021","unstructured":"Colunga-Pedraza IJ, Galarza-Delgado DA, Azpiri-Lopez JR, et al.. Nail involvement in psoriatic arthritis patients is an independent risk factor for carotid plaque. Ann Rheum Dis. 2021, 80:1629-31. 10.1136\/annrheumdis-2021-220782","journal-title":"Ann Rheum Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217595","article-title":"DAPSA, carotid plaque and cardiovascular events in psoriatic arthritis: a longitudinal study","volume":"79","author":"Lam SH","year":"2020","unstructured":"Lam SH, Cheng IT, Li EK, et al.. DAPSA, carotid plaque and cardiovascular events in psoriatic arthritis: a longitudinal study. Ann Rheum Dis. 2020, 79:1320-6. 10.1136\/annrheumdis-2020-217595","journal-title":"Ann Rheum Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1023\/b:ejep.0000020447.59150.f9","article-title":"Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients","volume":"19","author":"Mallbris L","year":"2004","unstructured":"Mallbris L, Akre O, Granath F, Yin L, Lindel\u00f6f B, Ekbom A, St\u00e5hle-B\u00e4ckdahl M. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol. 2004, 19:225-30. 10.1023\/b:ejep.0000020447.59150.f9","journal-title":"Eur J Epidemiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.14.1735","article-title":"Risk of myocardial infarction in patients with psoriasis","volume":"296","author":"Gelfand JM","year":"2006","unstructured":"Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006, 296:1735-41. 10.1001\/jama.296.14.1735","journal-title":"JAMA"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.09020.x","article-title":"Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis","volume":"160","author":"Brauchli YB","year":"2009","unstructured":"Brauchli YB, Jick SS, Miret M, Meier CR. Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis. Br J Dermatol. 2009, 160:1048-56. 10.1111\/j.1365-2133.2008.09020.x","journal-title":"Br J Dermatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206916","article-title":"Global effect of modifiable risk factors on cardiovascular disease and mortality","volume":"389","author":"Magnussen C","year":"2023","unstructured":"Magnussen C, Ojeda FM, Leong DP, et al.. Global effect of modifiable risk factors on cardiovascular disease and mortality. N Engl J Med. 2023, 389:1273-85. 10.1056\/NEJMoa2206916","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/423812-psoriatic-arthritis-features-and-risk-of-cardiovascular-events-a-nationwide-cohort-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T02:46:05Z","timestamp":1763693165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/423812-psoriatic-arthritis-features-and-risk-of-cardiovascular-events-a-nationwide-cohort-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.97377","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,20]]}}}